A detailed history of Alta Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Alta Capital Management LLC holds 3,235 shares of ABBV stock, worth $628,495. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,235
Previous 3,360 3.72%
Holding current value
$628,495
Previous $611,000 9.33%
% of portfolio
0.04%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $19,348 - $22,595
-125 Reduced 3.72%
3,235 $554,000
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $39,955 - $45,525
-250 Reduced 6.93%
3,360 $611,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $33,983 - $39,136
-235 Reduced 6.11%
3,610 $575,000
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $17,288 - $20,733
-125 Reduced 3.15%
3,845 $0
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 4.8%
3,970 $608,000
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $31,015 - $38,481
235 Added 5.97%
4,170 $675,000
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $25,783 - $32,623
-240 Reduced 5.75%
3,935 $532,000
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $444,220 - $504,256
-4,175 Reduced 50.0%
4,175 $450,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $427,102 - $470,188
4,175 Added 100.0%
8,350 $903,000
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $392,388 - $529,766
-4,875 Reduced 53.87%
4,175 $447,000
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $289,476 - $438,881
4,488 Added 98.38%
9,050 $689,000
Q3 2019

Oct 22, 2019

SELL
$62.98 - $75.72 $11,966 - $14,386
-190 Reduced 4.0%
4,562 $345,000
Q1 2019

Apr 23, 2019

SELL
$77.14 - $90.79 $1.44 Million - $1.69 Million
-18,637 Reduced 79.68%
4,752 $382,000
Q4 2018

Jan 09, 2019

BUY
$77.85 - $96.01 $93,030 - $114,731
1,195 Added 5.38%
23,389 $2.16 Million
Q3 2018

Oct 17, 2018

BUY
$88.91 - $98.84 $62,148 - $69,089
699 Added 3.25%
22,194 $2.1 Million
Q2 2018

Jul 23, 2018

BUY
$89.78 - $106.23 $18,853 - $22,308
210 Added 0.99%
21,495 $1.99 Million
Q1 2018

Apr 06, 2018

SELL
$92.01 - $123.21 $24,198 - $32,404
-263 Reduced 1.22%
21,285 $2.01 Million
Q4 2017

Jan 18, 2018

SELL
$89.56 - $98.21 $523,567 - $574,135
-5,846 Reduced 21.34%
21,548 $2.08 Million
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $1.91 Million - $2.44 Million
27,394
27,394 $2.43 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alta Capital Management LLC Portfolio

Follow Alta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Capital Management LLC with notifications on news.